Mar 26, 2018 11:00 am UTC| Business
TORONTO, March 26, 2018 -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB:SNIPF) (TSX-V:SPN), a global provider of digital marketing promotions, rebates and loyalty solutions, shared their perspective with The...
Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board
Mar 26, 2018 11:00 am UTC| Business
HAIFA, Israel, March 26, 2018 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that Dr. Roger Jeffs has joined Pluristem’s strategic...
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
Mar 26, 2018 11:00 am UTC| Business
THOROFARE, N.J., March 26, 2018 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has entered into a three-year National...
Akcea Convenes First FCS Global Connection Summit
Mar 26, 2018 11:00 am UTC| Business
CAMBRIDGE, Mass., March 26, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat people with serious and rare diseases,...
Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results
Mar 26, 2018 11:00 am UTC| Business
Fourth Quarter 2017 and Recent Business Highlights: Met enrollment targets and received positive feedback from the US FDA for Oraxol Phase III Clinical Trial in metastatic breast cancerAnnounced strategic partnership...
Mar 26, 2018 11:00 am UTC| Business
New Drug Application Submitted to U.S. Food and Drug Administration Marketing Authorization Application Submitted to European Medicines Agency THE WOODLANDS, Texas, March 26, 2018 -- Lexicon Pharmaceuticals, Inc....
Victory Capital Reports Fourth Quarter and Full Year 2017 Results
Mar 26, 2018 11:00 am UTC| Business
Fourth Quarter 2017 Highlights and Recent Developments1 Assets under management ("AUM") of $61.8 billion as of December 31, 2017, a 12% year-over-year increaseStrong investment performance, with 88% of AUM outperforming...